EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,777 | -19.4% | 112,666 | -0.7% | 0.65% | -6.4% |
| Q2 2023 | $2,205 | -31.7% | 113,437 | -0.3% | 0.70% | -28.7% |
| Q1 2023 | $3,227 | -3.8% | 113,737 | -0.9% | 0.98% | -5.5% |
| Q4 2022 | $3,356 | -99.9% | 114,825 | -5.2% | 1.04% | +1.8% |
| Q3 2022 | $3,199,000 | -40.5% | 121,083 | +0.1% | 1.02% | -42.7% |
| Q2 2022 | $5,377,000 | -5.4% | 121,014 | +5.4% | 1.78% | -9.2% |
| Q1 2022 | $5,681,000 | +4.8% | 114,787 | +7.8% | 1.96% | +4.1% |
| Q4 2021 | $5,422,000 | -9.8% | 106,487 | -1.2% | 1.88% | -0.3% |
| Q3 2021 | $6,012,000 | +98.4% | 107,773 | +52.2% | 1.89% | +83.3% |
| Q2 2021 | $3,030,000 | – | 70,804 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |